Evidence map›Paper›PMID 28495681›Full record

Trial reportSexually transmitted infections2017

A comparative analysis of costs of single and dual rapid HIV and syphilis diagnostics: results from a randomised controlled trial in Colombia.

Carol Dayo Obure, Hernando Gaitan-Duarte, Ricardo Losada Saenz, Lina Gonzalez, Edith Angel-Muller, Maura Laverty, Freddy Perez

Registry-linked trialOpen access · hybridAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Sexually transmitted infections, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02454816 (Introduction Study of Dual HIV & Syphilis Rapid Diagnostic Tests in Antenatal Clinics in COLOMBIA), which is not on this map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02454816 nacompletednot on this map

Introduction Study of Dual HIV & Syphilis Rapid Diagnostic Tests in Antenatal Clinics in COLOMBIA

TypeinterventionalSponsorUniversidad Nacional de ColombiaRan2014 to 2015Enrolled12ConditionsSyphilis, HIVArmsSingle HIV RDT and single syphilis RDT, Dual HIV/syphilis RDT
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Carol Dayo ObureDepartment of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
Hernando Gaitan-DuarteObstetrics and Gynecology Department, Universidad Nacional de Colombia, Bogotá, Colombia.
Ricardo Losada SaenzObstetrics and Gynecology Department, Universidad Nacional de Colombia, Bogotá, Colombia.
Lina GonzalezObstetrics and Gynecology Department, Universidad Nacional de Colombia, Bogotá, Colombia.
Edith Angel-MullerObstetrics and Gynecology Department, Universidad Nacional de Colombia, Bogotá, Colombia.
Maura LavertyDepartment of Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Freddy PerezCommunicable Diseases and Health Analysis Department, HIV, Hepatitis, Tuberculosis and Sexually Transmitted Infections Unit, Pan American Health Organization, Washington DC, USA.
Universidad Nacional de Colombia · COLondon School of Hygiene & Tropical Medicine · GBWorld Health Organization · CHWorld Health Organization Regional Office for the Americas · US

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundHIV and congenital syphilis are major public health burdens contributing to substantial perinatal morbidity and mortality globally. Although studies have reported on the costs and cost-effectiveness of rapid diagnostic tests (RDTs) for syphilis screening within antenatal care in a number of resource-constrained settings, empirical evidence on country-specific cost and estimates of single RDTs compared with dual RDTs for HIV and syphilis are limited.

methodsA cluster randomised controlled study design was used to compare the incremental costs of two testing algorithms: (1) single RDTs for HIV and syphilis and (2) dual RDTs for HIV and syphilis, in 12 health facilities in Bogota and Cali, Colombia. The costs of single HIV and syphilis RDTs and dual HIV and syphilis RDTs were collected from each of the health facilities. The economic costs per woman tested for HIV and syphilis and costs per woman treated for syphilis defined as the total costs required to test and treat one woman for syphilis were estimated.

resultsA total of 2214 women were tested in the study facilities. Cost per pregnant woman tested and cost per woman treated for syphilis were US$10.26 and US$607.99, respectively in the single RDT arm. For the dual RDTs, the cost per pregnant woman tested for HIV and syphilis and cost per woman treated for syphilis were US$15.89 and US$1859.26, respectively. Overall costs per woman tested for HIV and syphilis and cost per woman treated for syphilis were lower in Cali compared with Bogota across both intervention arms. Staff costs accounted for the largest proportion of costs while treatment costs comprised <1% of the preventive programme.

conclusionsFindings show lower average costs for single RDTs compared with dual RDTs with costs sensitive to personnel costs and the scale of output at the health facilities. TRIAL REGISTRATION NUMBER: NCT02454816; results.

Indexed as

ColombiaCost-Benefit AnalysisDiagnostic Tests, RoutineFemaleHIV InfectionsHumansInfectious Disease Transmission, VerticalMass ScreeningPolicy MakingPregnancyPregnancy Complications, InfectiousPrenatal CarePrenatal DiagnosisProspective StudiesPublic HealthSyphilisANTENATAL HIVLATIN AMERICASYPHILIS

Identifiers

PMID28495681
PMCPMC5739853
OpenAlexW2613459947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.